Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1367-1370, July 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, H. G.
Right arrow Articles by Bach, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, H. G.
Right arrow Articles by Bach, M. K.

Apparent Antimutagenic Activity of Quinacrine Hydrochloride in Detroit-98 Human Sternal Marrow Cells Grown in Culture

Herbert G. Johnson1 and Michael K. Bach2

The Upjohn Company, Research Division, Kalamazoo, Michigan 49001

The ability of a small proportion of the cells in cultures of Detroit-98 (D-98) human sternal marrow cells to attach to glass in the presence of 8-azaguanine has been previously shown to be caused by a mutation to resistance to this compound. This paper presents results of experiments dealing with the effect of the addition of quinacrine hydrochloride to the culture medium of D-98 cells on the frequency of this mutation. Such cells have been previously shown to be azaguanine-resistant mutants. In three independent experiments, cultures which were grown for several subcultivations in the presence of 0.06 µg/ml of quinacrine hydrochloride contained one-half to one-third the mean number of azaguanine-resistant mutants found in control cultures. On the other hand, the incorporation of quinacrine hydrochloride into the culture medium of D-98/AG cells, an azaguanine-resistant subline of the D-98 line, had no effect on its cloning efficiency in the presence or absence of added azaguanine. The results are discussed as a possible confirmation of the proposed antimutagenic action of quinacrine hydrochloride on mammalian cells.

1 Present address: Department of Microbiology, University of Michigan, School of Medicine, Ann Arbor, Michigan.

2 All correspondence should be addressed to this author.

Received 11/18/68. Accepted 3/18/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.